JUN and acute myeloid leukemia: High expression of WT1 is related to proliferative alteration, increased numbers of blasts, progression to AML and repression of pro-apoptotic genes, such as BAK, which in turn contributes to the survival of neoplastic cells.40,41 NT157 treatment resulted in increased FOS and JUN gene expression and JNK activation.